SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-22-002987
Accepted
2022-10-11 00:15:35
Documents
1
Effectiveness Date
2022-10-07
Registration Form
POS AM
Reference AccNo
0001213900-22-057177

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 609
  Complete submission text file 9999999995-22-002987.txt   1721
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: EFFECT | Act: 33 | File No.: 333-265731 | Film No.: 221301966
SIC: 2834 Pharmaceutical Preparations